Till now, mortality reports among children below 9 years remains extremely low despite that
the incidence of death toll is high and exceeding 50,000 patients among older population, One
speculation for lower SARS infectivity is that cross-protective antibodies against measles
vaccine ( MV). In mice susceptible to measles virus, recombinant MV induced the highest
titers of neutralizing antibodies and fully protected immunized animals from intranasal
infectious challenge with SARS-CoV,
The primary objective of the present study is to determine the benefit of measles vaccine in
health care professional to decrease the incidence of COVID-19.
We Hypothesized that, measles vaccine may lower the incidence of serologically proven
SARS-CoV-2 infection and reported respiratory illness